● Recruiting

First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury

Condition: Spinal Cord Injury · Chronic Spinal Cord Injury · Sponsor: Yonsei University

PhasePhase 1/Phase 2

Planned participants9

Who can joinAll sexes, 19 Years to 60 Years

Healthy volunteersNo

About this study

This study aim to investigate the safety and exploratory efficacy of STUP-001 which is AAV-based spinal cord injury investigational product.

This description comes directly from the study's public registry record.

Talk to the study team

Junsang Yoo, Ph D. · 82-2-512-0912 · info@stutps.com

Chunggu Kim, Ph D. · +82-10-9784-2722 · chunggoo@stutps.com

Always discuss trial participation with your own doctor first.

Locations (1)

Severance Hospital

Seoul, South Korea

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06922890